Website Navigation for Screen Readers

Menu

Internal Funding Opportunities

Below are internal funding opportunities that have been submitted from centers and institutes across Johns Hopkins University. Please note that this may not be an all-inclusive list of internal opportunities. If you have an opportunity you would like us to publicize here and in the monthly digest email, please fill out this form by the last Wednesday of each month for inclusion in the following digest.

If you would like to be added to the monthly internal funding opportunity announcement listserv, please contact RDT.

INTERNAL FUNDING OPPORTUNITIES FOR JUNE 1, 2022

Funding Sponsor Program Title Max Amount of Award Due Date Notification Date
Institute for Clinical & Translational Research (ICTR) Boost and Propel Research Awards CRU resources June 20, 2022 TBD
BOOST and PROPEL awards are clinical research grants that will be accepted on a quarterly basis, that award Clinical Research Unit (CRU) resources such as research space including overnight beds, phlebotomy, specialized research nursing, and CRU-based imaging (i.e. DXA, CV core) to investigators, based on scientific merit. Research studies will be monitored by the Translational Research Evaluation Committee (TREC) for study-specific milestones. The goal of the BOOST and PROPEL award is designed to accelerate meritorious protocols to produce efficient, high quality, safe and disseminatable research. PROPEL and BOOST awards are unique within the ICTR in that: 1) awards are for CRU resources, and 2) applicants undergo a rigorous, NIH-style, multidisciplinary review process via the TREC review committee. BOOST and PROPEL projects are monitored on a quarterly basis for attainment of milestones.
Eligibility: BOOST: BOOST awards are for junior investigators, first-time R01 awardees, K awardees, and KL2 scholars to generate pilot data for a larger grant submission or to supplement research funds for the K project. Researchers with advanced degrees (PhD, MD, or equivalent) and are in an Assistant Professor or equivalent position can apply for funding. Undergraduates, graduate students, and postdoctoral fellows are not eligible to apply as Principal or Co-Investigators but can be incorporated as team members into any proposal. Applicants identified as the PI have primary responsibility for the grant submission, and if subsequently selected for funding, all work to be performed as well as all reporting requirements and other stipulations which must be satisfied as a condition of receiving this award. Awards WILL NOT be transferred to another investigator post-award.
PROPEL: PROPEL awards are intended for established investigators who are performing early stage clinical trials, deep phenotyping studies, or studies that address Maryland health priorities. PROPEL can augment resources of a funded project or provide resources for small pilot and feasibility studies. Researchers with advanced degrees (PhD, MD, or equivalent) and are at least an Assistant Professor or equivalent position can apply for funding. Undergraduates, graduate students, and postdoctoral fellows are not eligible to apply as Principal or Co-Investigators but can be incorporated as team members into any proposal. Applicants identified as the PI have primary responsibility for the grant submission, and if subsequently selected for funding, all work to be performed as well as all reporting requirements and other stipulations which must be satisfied as a condition of receiving this award. Awards WILL NOT be transferred to another investigator post-award.

 

Neurofibromatosis Therapeutic Acceleration Program, Johns Hopkins School of Medicine Developmental and Hyperactive Ras Tumor (DHART) SPORE: Developmental Research Program $75,000 July 20, 2022 TBD
The IU School of Medicine Department of Pediatrics is a member of the multi-institutional Developmental and Hyperactive Ras Tumor (DHART) SPORE program. The goal of the SPORE program is to improve the diagnosis and management of tumors arising in persons with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes through basic, translational, and clinical research. The DRP supports innovative pilot projects to advance the diagnosis and treatment of early stage tumors and advanced cancers characterized by germline and somatic NF1 mutations through rigorous translational research in the areas of population science, therapeutics, and mechanisms of disease and by facilitating collaborative interactions between DRP-funded scientists and other SPORE investigators.
Eligibility: Proposals are accepted from clinical or basic science investigators at any DHART SPORE institution as well as from other academic institutions. Application is limited to faculty who are scientifically independent by the criteria of eligibility to apply for NIH R01 awards, but who do not currently hold R01 or equivalent funding for NF1-related research. Faculty members with NIH career development awards (K08; K23) are not eligible to apply for DRP funds. Faculty members from under-represented in medicine (URM) groups and historically black colleges and universities (HBCU) are strongly encouraged to apply.

 

Neurofibromatosis Therapeutic Acceleration Program, Johns Hopkins School of Medicine Developmental and Hyperactive Ras Tumor (DHART) SPORE: Career Enhancement Program $75,000 July 20, 2022 TBD
The Career Enhancement Program (CEP) is a component of the multi-institutional Developmental and Hyperactive Ras Tumor (DHART) SPORE. This SPORE focuses on improving the diagnosis and management of tumors arising in persons with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes through basic, translational, and clinical research. The goals of the DHART SPORE Career Enhancement Program are: (1) to attract outstanding early stage basic, translational and clinical investigators to the field of NF1-assocaited tumor research; (2) to assist in the career development of these early stage faculty; and, (3) to encourage collaborations between investigators that can lead to new ideas and directions in research related to tumors associated with NF1 mutations while also contributing to career development.
Eligibility: Proposals will be accepted from clinical, population, and basic science investigators at DHART SPORE and non-SPORE academic institutions. In keeping with the SPORE program guidelines, the CEP has a strong emphasis on supporting the career development of young invesigators who engage in clinical and translational research. Applicants must have faculty appointments and be eligible to apply for NIH K and R series awards at their current institution. Applicants may not hold R01 or equivalent funding for NF1-related research as a Principal Investigator. Faculty members who hold career development awards (K08; K23 or similar) are eligible to apply for CEP funds.

 

Neurofibromatosis Therapeutic Acceleration Program, Johns Hopkins School of Medicine Biology and Therapeutic Development for NF1 Associated Cutaneous Neurofibromas $1,000,000 Letter of Intent: August 5, 2022
Full Application: September 2, 2022
November 7, 2022
NTAP is launching a new initiative to advancing meaningful therapeutic discovery for NF1 associated cNF: the Biology and Therapeutic Development for Cutaneous Neurofibromas Initiative. A core element of this new cNF initiative is the Request of Applications for research projects focused on cNF. Areas of special interest include: (1) Investigate the processes underlying the stages of cNF initiation, progression, maintenance and senescence; (2) Identify and validate therapeutic candidates across the various stages and expressions of cNF; (3) Identify or validate non-invasive approaches in humans and preclinical systems for detection and assessment of growth or response of cNF; (4) Define or validate key variables and endpoints for cNF clinical trials; (5) Develop the infrastructure for patient-driven engagement programs to enable registries and rapid enrollment into clinical trials for cNF.
Eligibility: Investigators can be from academia, government, or private sector. International candidates, multidisciplinary teams and investigators new to NF1 are welcomed.

 

Johns Hopkins School of Medicine Tilghman Traveling Fellowship $15,000 Rolling basis Rolling basis
Established in 1976 by Dr. and Mrs. R. Carmichael Tilghman, this traveling fellowship is to be awarded annually to young members of the Medical Faculty to assist them during a sabbatical leave of up to one year to travel outside the Baltimore area to pursue new theories, methods and techniques in their chosen discipline. The funds are to be used toward travel, living expenses, and tuition costs for up to a one year period. No salary or research costs may be paid by these funds. Applications can be submitted at any time, but should be submitted at least 60 days prior to the proposed travel.
Eligibility: Both full and part time members of the Medical Faculty are eligible for consideration. The recipient must be a native born citizen of the United States and those applicants proposing studies which have a clinical application will be given the strongest consideration.

 

Johns Hopkins University Older Americans Independence Center Small Pilot Projects $10,000 (direct costs) Rolling basis Rolling basis
The Johns Hopkins Older Americans Independence Center (OAIC) solicits proposals to support of scientific projects and junior investigators in research on frailty in aging. The OAIC is a Johns Hopkins-wide Center, funded by the National Institute on Aging’s Center on Aging and Health, to support the development of research on the etiology of frailty as a basis for developing treatments or approaches to prevention of frailty in older adults. Scientists with an interest in developing pilot projects in this area or with needs for support of biostatistical or genetic analyses of data related to frailty, as well as junior faculty seeking protected time to develop investigative careers in this field, are encouraged to apply for internal funding through the OAIC mechanisms. Small pilot proposals must have a hypothesis that is frailty-focused.
Eligibility:  Anyone may apply.

 

The Ignite Fund The Ignite Fund unlimited Rolling basis TBD
The Ignite Fund offers Hopkins student entrepreneurs access to funding throughout the academic year. The fund’s purpose is to support discrete tasks that will help move a venture forward. In focusing funding this way, we hope to provide student ventures access to capital at key moments. Applications must identify a single discrete task to be funded. Applicant(s) must clearly demonstrate how the task to be achieved by the funding will impact their venture’s next steps. All proposals will be considered, but, in light of limited funding, successful applications will emphasize how to make the most out of minor amounts. All awards must complete their closing process (provision of final progress report and receipts) no later than May 15, 2022.
Eligibility: All ventures with at least one current JHU student founder. Ventures who have won Ignite Fund awards previously may apply again if they have completed the closing process (provision of final progress report and receipts) prior to their newest application.

 

  • Contact

    Vice Provost for Research

    265 Garland Hall
    3400 North Charles Street
    Baltimore, MD 21218

    (443) 927-1957

  • Social

  • Website Footer Navigation